21 June 2020 in Korean Journal of Otorhinolaryngology-Head and Neck Surgery
Vestibular schwannoma is a rare tumor that develops in the nerves responsible for vestibular function and hearing. It usually affects middle-aged people, and is diagnosed by hearing and imaging tests. In the majority of cases, it occurs in the retro-cochlear space and very rarely in the labyrinth. Several vestibular schwannoma localized in the labyrinth have been reported worldwide. Since then 5 cases have been reported. With advances in the imaging study, the diagnosis of intralabyrinthine schwannomas have increased. Our report describes the characteristics and treatments of intralabyrinthine schwannomas reported in Korea, including five previously reported cases and the case experienced by authors.
30 November 2025 in Journal of Rhinology
Background and Objectives: In June 2018, South Korea expanded insurance coverage for polysomnography (PSG) to improve diagnostic access for obstructive sleep apnea (OSA). This study investigated the impact of this policy by analyzing changes in PSG utilization and diagnostic outcomes.Methods: A multicenter retrospective study was conducted using data from 17 tertiary hospitals across South Korea. Patients aged ≥20 years who visited the hospitals for suspected OSA between 2015 and 2023 were included. The pre-coverage period was defined as 2015–2017, and the post-coverage period as 2019–2023. Demographics, PSG implementation rates, and apnea-hypopnea index (AHI) distributions were compared.Results: A total of 29,055 patients were included (7,800 pre-coverage; 21,255 post-coverage). PSG utilization significantly increased from 51.3% to 74.4% (p<0.001). The proportion of female patients rose from 20.0% to 23.0%, and the mean age increased from 45.8 to 49.8 years (p<0.001). The average AHI increased from 31.2 to 35.3. The proportion of patients with severe OSA (AHI ≥30) rose from 42.8% to 48.8%, while cases with normal AHI (<5) declined from 11.6% to 8.3% (p<0.001).Conclusion: The expansion of insurance coverage significantly improved PSG accessibility, particularly for older adults, women, and high-risk patients. The observed shift toward more severe diagnoses suggests enhanced detection of untreated OSA rather than overdiagnosis of mild or normal cases. These findings support the ongoing implementation of inclusive health policies while emphasizing the importance of appropriate patient selection.
31 July 2026 in Journal of Rhinology
Merocel, a polyvinyl acetal sponge, is a nonabsorbable nasal packing material widely used after sinonasal surgery because of its hemostatic efficacy and ease of placement. However, nonabsorbable packing is generally removed within 48 hours to reduce the risks of mucosal injury, infection, and adhesion. A 48-year-old man underwent endoscopic sinus surgery (ESS) for chronic rhinosinusitis at a secondary hospital. The Merocel pack was inadvertently retained for 50 days, resulting in acute pansinusitis with foul odor, postnasal drip, and facial pain. Attempts to remove the packing by traction and irrigation at the secondary hospital were unsuccessful and caused fragmentation of the Merocel. The patient was subsequently referred to our tertiary center, where revision ESS revealed firmly adherent Merocel fragments. Histopathological examination demonstrated inflammatory tissue ingrowth into the porous Merocel structure without bone fragment entrapment or osseous ingrowth. The patient recovered uneventfully, with no recurrence at the 3-month follow-up. Prolonged retention of a Merocel nasal pack may cause acute sinusitis and firm adhesion through inflammatory tissue ingrowth, even without histopathological evidence of bone involvement. Prevention requires timely pack removal, structured follow-up, and comprehensive patient education.
10 July 2025 in Journal of the Korean Medical Association
Purpose: Chronic rhinosinusitis (CRS) is a persistent inflammatory disease of the sinonasal mucosa that significantly impacts patients’ quality of life. This review discusses the latest literature regarding the epidemiology and diagnostic criteria of CRS, aiming to provide practical insights for clinical use.Current Concepts: CRS is characterized by abnormal symptoms that persist despite at least eight weeks of pharmacological treatment. Its diagnosis is primarily based on clinical symptoms, imaging studies, and endoscopic findings. In this paper, we summarize essential information on the primary diagnostic criteria, classifications, and clinical approaches to CRS for general practitioners. The review highlights the importance of differentiating between CRS with nasal polyps and CRS without nasal polyps, leveraging imaging techniques such as computed tomography, and incorporating biomarkers and endotyping strategies to improve diagnostic accuracy.Discussion and Conclusion: This review aims to promote a deeper understanding of current knowledge regarding the epidemiology of CRS and to encourage the use of diagnostic criteria and classification systems such as CRS endotyping to support improved patient care and treatment outcomes.
15 May 2026 in Clinical and Experimental Otorhinolaryngology